Skip to Main Content
Skip Nav Destination






(LAR oh TREK ti nib)

Brand Names: US

  • Vitrakvi

Therapeutic Category

  • Antineoplastic Agent, Tropomyosin Receptor Kinase (TRK) Inhibitor

Medication Safety Issues

Sound-alike/look-alike issues:

Larotrectinib may be confused with alectinib, entrectinib, lapatinib, lenvatinib, lonafarnib, lorlatinib.

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its lists of drug classes which have a heightened risk of causing significant patient harm when used in error.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal